KIR2DL3 and Graves disease: Overall, two genetic variants, rs1521 and rs3094228, associated with, respectively, Graves’ disease and TPOAb-positivity, appear to alter thyrocyte expression of ligands of two immunoreceptors of NK cells, CD314 and CD158b; both of which have the capacity to enhance cytotoxicity of NK cells after binding with target cells.